Table 2.
HPV | Non-HPV | P | ||
---|---|---|---|---|
Total | 939,874 | 1,878,748 | ||
Gender | ||||
Male | 472,420(50.26%) | 944,840(50.26%) | ||
Female | 467,454(49.74%) | 934,908(49.74%) | ||
Age | ||||
<20 | 256,500(27.29%) | 513,000(27.29%) | 1.0,000 | |
20–40 | 334,686(35.61%) | 669,372(35.61%) | ||
40–60 | 234,575(24.96%) | 469,150(24.96%) | ||
60–80 | 95,755(10.19%) | 191,510(10.19%) | ||
≥80 | 18,358(1.95%) | 36,716(1.95%) | ||
Co–morbidities | ||||
Ischemic heart disease | 39,334(4.19%) | 63,872(3.40%) | <0.0,001 | |
Hypertension | 112,709(11.99%) | 205,015(10.91%) | <0.0,001 | |
Hyperlipidemia | 83,114(8.84%) | 133,790(7.12%) | <0.0,001 | |
Stroke | 20,246(2.15%) | 40,087(2.13%) | 0.2,386 | |
Diabetes mellitus | 46,782(4.98%) | 96,584(5.14%) | <0.0,001 | |
Abnormal liver function | 45,661(4.86%) | 91,126(4.85%) | 0.7,009 | |
Peptic ulcer | 74,302(7.91%) | 122,250(6.50%) | <0.0,001 | |
GI bleeding | 5,723(0.61%) | 10,826(0.58%) | 0.0,006 | |
Renal failure | 8,191(0.87%) | 15,200(0.81%) | <0.0,001 | |
Chronic kidney diseases | 14,747(1.57%) | 25,740(1.37%) | <0.0,001 | |
Gout | 28,685(3.05%) | 49,184(2.62%) | <0.0,001 | |
COPD | 18„607(1.98%) | 32,326(1.72%) | <0.0,001 | |
Urbanization | ||||
Urban 1 | 319,694(34.01%) | 542,433(28.86%) | <0.0,001 | |
2 | 290,511(30.91%) | 587,017(31.23%) | ||
3 | 162,859(17.33%) | 340,505(18.11%) | ||
4 | 109,824(11.68%) | 246,844(13.13%) | ||
5 | 13,197(1.40%) | 36,687(1.95%) | ||
6 | 23,620(2.51%) | 70,850(3.77%) | ||
Rural 7 | 20,169(2.15%) | 55,412(2.95%) | ||
Occupation | ||||
Officer | 79,002(8.41%) | 111,753(5.95%) | <0.0,001 | |
Laborer | 618,860(65.84%) | 1,183,084(62.94%) | ||
Farmer | 94,224(10.03%) | 237,256(12.62%) | ||
Low income | 7,928(0.84%) | 20,772(1.11%) | ||
Unemployed | 122,182(13.00%) | 29,4431(15.66%) | ||
Others | 17,678(1.88%) | 32,452(1.73%) |